Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1981 1
1984 1
1985 1
1999 1
2000 1
2001 1
2006 1
2007 2
2008 1
2009 4
2010 5
2011 4
2012 4
2013 8
2014 11
2015 15
2016 19
2017 30
2018 32
2019 16
2020 20
2021 16
2022 9
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 28641170

172 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Toledano R, Jovel CE, Jiménez-Huete A, Bayarri PG, Campos D, Gomariz EL, Giráldez BG, García-Morales I, Falip M, Agredano PM, Palao S, Prior MJAA, Pascual MRQ, Navacerrada FJ, González FJL, Ojeda J, Sáez AA, Bermejo PE, Gil-Nagel A. Toledano R, et al. Epilepsy Behav. 2017 Aug;73:173-179. doi: 10.1016/j.yebeh.2017.02.028. Epub 2017 Jun 20. Epilepsy Behav. 2017. PMID: 28641170
Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures.
Andermann E, Biton V, Benbadis SR, Shneker B, Shah AK, Carreño M, Trinka E, Ben-Menachem E, Biraben A, Rocha F, Gama H, Cheng H, Blum D; Study 301, 302 and 304 Investigators. Andermann E, et al. Epilepsy Behav. 2018 May;82:119-127. doi: 10.1016/j.yebeh.2017.12.017. Epub 2018 Mar 28. Epilepsy Behav. 2018. PMID: 29604484 Free article.
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Villanueva V, Bermejo P, Montoya J, Massot-Tarrús A, Galiano ML, Toledo M, Rodriguez-Uranga JJ, Bertol V, Mauri JÁ, Poza JJ, Bonet M, Castro-Vilanova MD, Ruiz-Giménez J, López-González FJ, Rodríguez-Osorio X, Tortosa-Conesa D, Ojeda J, Giner P, Garcés M, Alvarez BM, Quiroga-Subirana P, Esteve P, Baiges JJ, Hampel K. Villanueva V, et al. Epilepsy Behav. 2019 Aug;97:51-59. doi: 10.1016/j.yebeh.2019.05.003. Epub 2019 Jun 7. Epilepsy Behav. 2019. PMID: 31181429
Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.
Sperling MR, Abou-Khalil B, Harvey J, Rogin JB, Biraben A, Galimberti CA, Kowacs PA, Hong SB, Cheng H, Blum D, Nunes T, Soares-da-Silva P; 304 Study Team. Sperling MR, et al. Epilepsia. 2015 Feb;56(2):244-53. doi: 10.1111/epi.12894. Epub 2014 Dec 22. Epilepsia. 2015. PMID: 25528898 Free PMC article. Clinical Trial.
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Elger C, Halász P, Maia J, Almeida L, Soares-da-Silva P; BIA-2093-301 Investigators Study Group. Elger C, et al. Epilepsia. 2009 Mar;50(3):454-63. doi: 10.1111/j.1528-1167.2008.01946.x. Epub 2009 Feb 21. Epilepsia. 2009. PMID: 19243424 Free article. Clinical Trial.
172 results